Otrexup
These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . OTREXUP (methotrexate) injection, for subcutaneous useInitial U.S. Approval: 1953
9ab8ce16-f7de-41d4-a4c8-1c742621b6d5
HUMAN PRESCRIPTION DRUG LABEL
Dec 14, 2023
Antares Pharma, Inc.
DUNS: 085369585
Products 8
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
methotrexate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
methotrexate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
methotrexate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
methotrexate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
methotrexate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
methotrexate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
methotrexate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
methotrexate
Product Details
FDA regulatory identification and product classification information